Literature DB >> 24814346

PTEN is a protein tyrosine phosphatase for IRS1.

Yuji Shi1, Junru Wang1, Sarat Chandarlapaty2, Justin Cross3, Craig Thompson3, Neal Rosen4, Xuejun Jiang1.   

Abstract

The biological function of the PTEN tumor suppressor is mainly attributed to its lipid phosphatase activity. This study demonstrates that mammalian PTEN is a protein tyrosine phosphatase that selectively dephosphorylates insulin receptor substrate-1 (IRS1), a mediator of insulin and IGF signals. IGF signaling was defective in cells lacking NEDD4, a PTEN ubiquitin ligase, whereas AKT activation triggered by EGF or serum was unimpaired. Defective IGF signaling caused by NEDD4 deletion, including phosphorylation of IRS1 and AKT, was rescued by PTEN ablation. We demonstrate the nature of PTEN as an IRS1 phosphatase by direct biochemical analysis and cellular reconstitution, showing that NEDD4 supports insulin-mediated glucose metabolism and is required for the proliferation of IGF1 receptor-dependent but not EGF receptor-dependent tumor cells. Thus, PTEN is a protein phosphatase for IRS1, and its antagonism by NEDD4 promotes signaling by IGF and insulin.

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 24814346      PMCID: PMC4167033          DOI: 10.1038/nsmb.2828

Source DB:  PubMed          Journal:  Nat Struct Mol Biol        ISSN: 1545-9985            Impact factor:   15.369


  44 in total

1.  E3 ubiquitin ligase Cbl-b regulates Pten via Nedd4 in T cells independently of its ubiquitin ligase activity.

Authors:  Hui Guo; Guilin Qiao; Haiyan Ying; Zhenping Li; Yixia Zhao; Yanran Liang; Lifen Yang; Stanley Lipkowitz; Josef M Penninger; Wallace Y Langdon; Jian Zhang
Journal:  Cell Rep       Date:  2012-05-31       Impact factor: 9.423

2.  Regulation of PTEN/Akt and MAP kinase signaling pathways by the ubiquitin ligase activators Ndfip1 and Ndfip2.

Authors:  Thomas Mund; Hugh R B Pelham
Journal:  Proc Natl Acad Sci U S A       Date:  2010-06-07       Impact factor: 11.205

Review 3.  The functions and regulation of the PTEN tumour suppressor.

Authors:  Min Sup Song; Leonardo Salmena; Pier Paolo Pandolfi
Journal:  Nat Rev Mol Cell Biol       Date:  2012-04-04       Impact factor: 94.444

Review 4.  Spatial regulation of receptor tyrosine kinases in development and cancer.

Authors:  Jessica B Casaletto; Andrea I McClatchey
Journal:  Nat Rev Cancer       Date:  2012-05-24       Impact factor: 60.716

5.  HECT E3 ubiquitin ligase Nedd4-1 ubiquitinates ACK and regulates epidermal growth factor (EGF)-induced degradation of EGF receptor and ACK.

Authors:  Qiong Lin; Jian Wang; Chandra Childress; Marius Sudol; David J Carey; Wannian Yang
Journal:  Mol Cell Biol       Date:  2010-01-19       Impact factor: 4.272

6.  E3 ligase Nedd4 promotes axon branching by downregulating PTEN.

Authors:  Jovana Drinjakovic; Hosung Jung; Douglas S Campbell; Laure Strochlic; Asha Dwivedy; Christine E Holt
Journal:  Neuron       Date:  2010-02-11       Impact factor: 17.173

7.  PTEN protein phosphatase activity correlates with control of gene expression and invasion, a tumor-suppressing phenotype, but not with AKT activity.

Authors:  Priyanka Tibarewal; Georgios Zilidis; Laura Spinelli; Nick Schurch; Helene Maccario; Alexander Gray; Nevin M Perera; Lindsay Davidson; Geoffrey J Barton; Nick R Leslie
Journal:  Sci Signal       Date:  2012-02-28       Impact factor: 8.192

8.  AKT inhibition relieves feedback suppression of receptor tyrosine kinase expression and activity.

Authors:  Sarat Chandarlapaty; Ayana Sawai; Maurizio Scaltriti; Vanessa Rodrik-Outmezguine; Olivera Grbovic-Huezo; Violeta Serra; Pradip K Majumder; Jose Baselga; Neal Rosen
Journal:  Cancer Cell       Date:  2011-01-06       Impact factor: 31.743

9.  Ndfip1 regulates nuclear Pten import in vivo to promote neuronal survival following cerebral ischemia.

Authors:  Jason Howitt; Jenny Lackovic; Ley-Hian Low; Adam Naguib; Alison Macintyre; Choo-Peng Goh; Jennifer K Callaway; Vicki Hammond; Tim Thomas; Matthew Dixon; Ulrich Putz; John Silke; Perry Bartlett; Baoli Yang; Sharad Kumar; Lloyd C Trotman; Seong-Seng Tan
Journal:  J Cell Biol       Date:  2012-01-02       Impact factor: 10.539

10.  Functional analysis of the protein phosphatase activity of PTEN.

Authors:  Xiaoqun Catherine Zhang; Antonella Piccini; Michael P Myers; Linda Van Aelst; Nicholas K Tonks
Journal:  Biochem J       Date:  2012-06-15       Impact factor: 3.857

View more
  51 in total

1.  A PTEN translational isoform has PTEN-like activity.

Authors:  Xie Zhang; Bowei Yin; Fangfang Zhu; Guochang Huang; Hong Li
Journal:  Chin J Cancer Res       Date:  2015-10       Impact factor: 5.087

2.  Myeloid PTEN promotes chemotherapy-induced NLRP3-inflammasome activation and antitumour immunity.

Authors:  Yi Huang; Huanyu Wang; Yize Hao; Hualong Lin; Menghao Dong; Jin Ye; Lei Song; Yunzhi Wang; Qingqing Li; Benjie Shan; Yizhou Jiang; Hongqi Li; Zhiming Shao; Guido Kroemer; Huafeng Zhang; Li Bai; Tengchuan Jin; Chao Wang; Yuting Ma; Yongping Cai; Chen Ding; Suling Liu; Yueyin Pan; Wei Jiang; Rongbin Zhou
Journal:  Nat Cell Biol       Date:  2020-05-04       Impact factor: 28.824

3.  Synthetic Essentiality of Metabolic Regulator PDHK1 in PTEN-Deficient Cells and Cancers.

Authors:  Nilanjana Chatterjee; Evangelos Pazarentzos; Manasi K Mayekar; Philippe Gui; David V Allegakoen; Gorjan Hrustanovic; Victor Olivas; Luping Lin; Erik Verschueren; Jeffrey R Johnson; Matan Hofree; Jenny J Yan; Billy W Newton; John V Dollen; Charles H Earnshaw; Jennifer Flanagan; Elton Chan; Saurabh Asthana; Trey Ideker; Wei Wu; Junji Suzuki; Benjamin A Barad; Yuriy Kirichok; James S Fraser; William A Weiss; Nevan J Krogan; Asmin Tulpule; Amit J Sabnis; Trever G Bivona
Journal:  Cell Rep       Date:  2019-08-27       Impact factor: 9.423

Review 4.  Current clinical regulation of PI3K/PTEN/Akt/mTOR signalling in treatment of human cancer.

Authors:  Hui Jun Lim; Philip Crowe; Jia-Lin Yang
Journal:  J Cancer Res Clin Oncol       Date:  2014-08-22       Impact factor: 4.553

5.  Lycium barbarum Polysaccharide Promotes Nigrostriatal Dopamine Function by Modulating PTEN/AKT/mTOR Pathway in a Methyl-4-phenyl-1,2,3,6-tetrahydropyridine (MPTP) Murine Model of Parkinson's Disease.

Authors:  Xiaohong Wang; Lei Pang; Yanqing Zhang; Jiang Xu; Dongyi Ding; Tianli Yang; Qian Zhao; Fan Wu; Fei Li; Haiwei Meng; Duonan Yu
Journal:  Neurochem Res       Date:  2018-03-28       Impact factor: 3.996

Review 6.  PTEN proteoforms in biology and disease.

Authors:  Prerna Malaney; Vladimir N Uversky; Vrushank Davé
Journal:  Cell Mol Life Sci       Date:  2017-03-13       Impact factor: 9.261

7.  A Small Molecule That Switches a Ubiquitin Ligase From a Processive to a Distributive Enzymatic Mechanism.

Authors:  Stefan G Kathman; Ingrid Span; Aaron T Smith; Ziyang Xu; Jennifer Zhan; Amy C Rosenzweig; Alexander V Statsyuk
Journal:  J Am Chem Soc       Date:  2015-09-22       Impact factor: 15.419

8.  LncRNAs-directed PTEN enzymatic switch governs epithelial-mesenchymal transition.

Authors:  Qingsong Hu; Chunlai Li; Shouyu Wang; Yajuan Li; Bo Wen; Yanyan Zhang; Ke Liang; Jun Yao; Youqiong Ye; Heidi Hsiao; Tina K Nguyen; Peter K Park; Sergey D Egranov; David H Hawke; Jeffrey R Marks; Leng Han; Mien-Chie Hung; Bing Zhang; Chunru Lin; Liuqing Yang
Journal:  Cell Res       Date:  2019-01-10       Impact factor: 25.617

Review 9.  NEDD4: The founding member of a family of ubiquitin-protein ligases.

Authors:  Natasha Anne Boase; Sharad Kumar
Journal:  Gene       Date:  2014-12-17       Impact factor: 3.688

10.  Insulin Receptor Substrate 1, the Hub Linking Follicle-stimulating Hormone to Phosphatidylinositol 3-Kinase Activation.

Authors:  Nathan C Law; Mary E Hunzicker-Dunn
Journal:  J Biol Chem       Date:  2015-12-23       Impact factor: 5.157

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.